High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl
…, A Volland, A Walser, H Ulmer, L Pipperger… - Communications …, 2021 - nature.com
… Lisa Pipperger … Ludwig Knabl, Janine Kimpel, Annika Rössler, André Volland, Lisa Pipperger,
Lydia Riepler, Barbara Falkensammer, Wegene Borena & Dorothee von … Lisa Pipperger …
Lydia Riepler, Barbara Falkensammer, Wegene Borena & Dorothee von … Lisa Pipperger …
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
I Koske, A Rössler, L Pipperger… - … journal of cancer, 2019 - Wiley Online Library
The efficacy of cancer vaccines has been limited by the immunosuppressive tumor
microenvironment, which can be alleviated by immune checkpoint inhibitor (ICI) therapy. Here, we …
microenvironment, which can be alleviated by immune checkpoint inhibitor (ICI) therapy. Here, we …
Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
Background In early March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria
triggered the spread of SARS-CoV-2 throughout Austria and Northern Europe. In a previous …
triggered the spread of SARS-CoV-2 throughout Austria and Northern Europe. In a previous …
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
SARS-CoV-2 infection ranges from asymptomatic to severe with lingering symptomatology
in some. This prompted investigation of whether or not asymptomatic disease results in …
in some. This prompted investigation of whether or not asymptomatic disease results in …
Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants
L Pipperger, L Riepler, J Kimpel, A Siller… - …, 2021 - Taylor & Francis
Oncolytic viruses (OVs) can eradicate tumor cells and elicit antitumor immunity. VSV-GP, a
chimeric vesicular stomatitis virus (VSV) with the glycoprotein (GP) of the lymphocytic …
chimeric vesicular stomatitis virus (VSV) with the glycoprotein (GP) of the lymphocytic …
Xenoantigen-dependent complement-mediated neutralization of lymphocytic choriomeningitis virus glycoprotein-pseudotyped vesicular stomatitis virus in human …
L Pipperger, I Koske, N Wild, B Müllauer… - Journal of …, 2019 - Am Soc Microbiol
Neutralization by antibodies and complement limits the effective dose and thus the therapeutic
efficacy of oncolytic viruses after systemic application. We and others previously showed …
efficacy of oncolytic viruses after systemic application. We and others previously showed …
[HTML][HTML] Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP
SV Vijver, S Danklmaier, L Pipperger… - Frontiers in …, 2023 - frontiersin.org
Oncolytic viruses are currently tested as a novel platform for cancer therapy. These viruses
preferentially replicate in and kill malignant cells. Due to their microbial origin, treatment with …
preferentially replicate in and kill malignant cells. Due to their microbial origin, treatment with …
Follow-up study in the ski-resort Ischgl: antibody and T cell responses to SARS-CoV-2 persisted for up to 8 months after infection and transmission of virus was low …
Background In early March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria
initiated the spread of SARS-CoV-2 throughout Austria and Northern Europe. In a cross-…
initiated the spread of SARS-CoV-2 throughout Austria and Northern Europe. In a cross-…
Seroprevalence of anti-SARS-cov-2 IgG antibodies in tyrol, Austria: updated analysis involving 22,607 blood donors covering the period October 2021 to April 2022
L Seekircher, A Siller, M Astl, L Tschiderer, GA Wachter… - Viruses, 2022 - mdpi.com
Because a large proportion of the Austrian population has been infected with SARS-CoV-2
during high incidence periods in winter 2021/2022, up-to-date estimates of seroprevalence of …
during high incidence periods in winter 2021/2022, up-to-date estimates of seroprevalence of …
Seroprevalence, waning and correlates of anti-SARS-CoV-2 IgG antibodies in tyrol, austria: large-scale study of 35,193 blood donors conducted between June 2020 …
A Siller, L Seekircher, GA Wachter, M Astl, L Tschiderer… - Viruses, 2022 - mdpi.com
There is uncertainty about the seroprevalence of anti-SARS-CoV-2 antibodies in the
general population of Austria and about the waning of antibodies over time. We conducted a …
general population of Austria and about the waning of antibodies over time. We conducted a …
